Services search (in the department)
Illness | Number of cases |
---|---|
Hyperplasia of prostate (N40) | 47 |
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 38 |
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) | 33 |
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) | 21 |
Neoplasm of uncertain or unknown behaviour of urinary organs - Neoplasm of uncertain behavior of bladder (D41.4) | 14 |
Obstructive and reflux uropathy (N13.3) | 13 |
Urethral stricture (N35.8) | 11 |
Calculus of kidney and ureter - Calculus of ureter (N20.1) | 10 |
Other disorders of bladder - Bladder-neck obstruction (N32.0) | 5 |
Malignant neoplasm of testis (C62.1) | 4 |
Treatment | Number |
---|---|
Injection or administration of medicines into the urinary bladder (8-132.3) | 158 |
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 86 |
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) | 64 |
Insertion, exchange or removal of a ureteral stent (8-137.00) | 46 |
Use of an imaging procedure during an operation (3-992) | 41 |
Computer-assisted analysis of the images with 3D-analysis (3-990) | 35 |
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) | 30 |
Computed tomography (CT) of the abdomen without contrast medium (3-207) | 18 |
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 18 |
Surgical incision into diseased tissue in the urethra, with access through the urethra (5-585.1) | 17 |
Department key: 2200
Inpatient department
Bezeichnung | |
Teilnahme externe Qualitätssicherung | 0 |
No. | Explanation |
---|---|
CQ01 |
Number | Group |
---|---|
53 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
33 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
33 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
Job | Explanation |
---|---|
Student training (clinical traineeship / internship year) | |
Project-related cooperation with colleges and universities | Bachelor „Interprofessionelle Gesundheitsversorgung"in Kooperation mit der DHBW Heidenheim Bachelor"Soziale Arbeit"in Kooperation mit der DHBW Heidenheim Bachelor"Medizinische Wissenschaften für medizinische Assistentinnen"in Kooperation mit der DHBW Heidenheim |
No. | Training in other healing professions | Comment |
---|---|---|
HB19 | Nursing professionals | Praxisträger |
HB18 | Emergency paramedics (m/f) (training period 3 years) | In Kooperation mit dem Bayerischen Roten Kreuz |
HB03 | Physical therapist / physiotherapist (m/f) | In Zusammenarbeit mit der Berufsfachschule für Physiotherapie des BKH Günzburg |
HB07 | Surgical technical assistant (m/f) | In Kooperation mit dem Bildungszentrum Gesundheit und Pflege am Ostalb-Klinikum Aalen |
HB17 | Auxiliary nurse (m/f) | In Kooperation mit dem RKU Ulm |
Nicolas Kiechle
Direktor Klinikmanagement
Phone:
08221
-96-1721
Mail:
ed.urk-zg-nekinilk@elhceik.salocin
Elisabeth Rummel
Leitung Unternehmensentwicklung / Qualitätsmanagement
Phone:
08221
-9676-1003
Mail:
ed.urk-zg-nekinilk@lemmur.htebasile
Dr. Ulrich Kugelmann
CA Gefäßchirurgie/ Ärztlicher Direktor
Phone:
08221
-9676-1131
Mail:
ed.urk-zg-nekinilk@nnamleguk.hcrilu
Dr. Ulrich Kugelmann
Ärztl. Direktor, Vorsitzender der Arzneimittelkomission
Phone:
08221
-9676-1031
Mail:
ed.urk-zg-nekinilk@nnamleguk.hcirlu